GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Ending Cash Position

XSpray Pharma AB (OSTO:XSPRAY) Ending Cash Position : kr125.73 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Ending Cash Position?

XSpray Pharma AB's Ending Cash Position for the quarter that ended in Mar. 2025 was kr125.73 Mil.

XSpray Pharma AB's quarterly Ending Cash Position increased from Sep. 2024 (kr74.76 Mil) to Dec. 2024 (kr208.24 Mil) but then declined from Dec. 2024 (kr208.24 Mil) to Mar. 2025 (kr125.73 Mil).

XSpray Pharma AB's annual Ending Cash Position increased from Dec. 2022 (kr120.17 Mil) to Dec. 2023 (kr166.30 Mil) and increased from Dec. 2023 (kr166.30 Mil) to Dec. 2024 (kr208.24 Mil).

XSpray Pharma AB Ending Cash Position Historical Data

The historical data trend for XSpray Pharma AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Ending Cash Position Chart

XSpray Pharma AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 325.60 271.88 120.17 166.30 208.24

XSpray Pharma AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.16 126.57 74.76 208.24 125.73

XSpray Pharma AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

XSpray Pharma AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=166.303+41.933
=208.24

XSpray Pharma AB's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=208.236+-82.511
=125.73

XSpray Pharma AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Ending Cash Position
Comparable Companies
OSTO:EGTX OSTO:GENO OSTO:SANION OSTO:SYNACT OSTO:VICO OSTO:DMYD B XSAT:HAMLET B OSTO:HNSA OSTO:IBT B OSTO:BINV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
0GHZ:UK
Address
Scheeles vag 2, Solna, SWE, SE-171 65
Website
https://www.xspraypharma.com
XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.

XSpray Pharma AB Headlines

No Headlines